Knowledge and Practices of ADR Reporting in LMICs

Clinical trial NCT04301219 · COMPLETED

Trial details

NCT number: NCT04301219
Sponsor: Getz Pharma
Status: COMPLETED
Study type: OBSERVATIONAL

Adverse Reaction

Start date: 2017-04-01
Primary completion: 2018-03-01
Enrollment: 1500

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.